Company: LRHC
Filing Date: 2025-06-03
Form Type: CORRESP
Source: 0001213900-25-050887
Chunk: 1

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-03
Form: CORRESP
Chunk 1
---

as a conduit for the Company and that the resale of the shares of the Company’s common stock to be registered by the Registration
Statement (the “Shares”) is not an indirect primary offering being conducted by or on behalf of the Company.

<div align='center'>1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036
T (212)
930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</div>

Background

On February 4, 2025 (the “Closing Date”),
the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an investor, JAK Opportunities
XI LLC, (the “Selling Stockholder”) for a private placement offering, or the Private Placement, of the following securities
of the Company: (i) a Senior Secured Convertible Note in the original principal amount of $5,500,000 which matures on the two-year anniversary
of the Closing Date (the “Initial Note”); and (ii) sixteen (16) warrants (“Incremental Warrants”),
each to purchase additional Senior Secured Convertible Notes each in an original principal amount up to $2,500,000 at an exercise price
of $2,256,250 (“Incremental Notes”; and together with the Initial Note, the “Notes”). The Company
also granted the Selling Stockholder registration rights in the Shares issuable upon conversion of the Notes under a separate Registration
Rights Agreement (the “Registration Rights Agreement”).

The conversion price of the Initial Note is $0.45494
per share of common stock; the Selling Stockholder may also convert at the “Alternate Conversion Rate” described
in the Initial Note. The Selling Stockholder does not have the right to convert any portion of the Initial Note to the extent that, after
such conversion, the Selling Stockholder would beneficially own in excess of 4.99% of outstanding shares of common stock of the Company.

The Incremental Warrants and Initial Note were
issued to the Seller Stockholder on the Closing Date.

As reported on Current Report on Form 8-K filed
by the Company with the SEC on May 28, 2025, on May 23, 2025, the Company and the Selling Stockholder entered into that certain waiver
agreement (the “Waiver”), dated May 23, 2025, pursuant to which the Selling Stockholder waived a